Discovery of a Highly Tumor-Selective
Organometallic
Ruthenium(II)–Arene Complex
- Publication date
- Publisher
Abstract
A ruthenium(II)–arene complex
with a perfluoroalkyl-ligand
was found to display remarkable selectivity toward cancer cells. IC<sub>50</sub> values on several cancer cell lines are in the range of
25–45 μM, and no cytotoxic effect was observed on nontumorigenic
(HEK-293) cells at concentrations up to 500 μM (the maximum
concentration tested). Consequently, this complex was used as the
basis for the development of a number of related derivatives, which
were screened in cancerous and noncancerous cell lines. The lead compound
was then evaluated in vivo for antiangiogenic activity in the CAM
model and in a xenografted ovarian carcinoma tumor (A2780) grown on
the CAM. A 90% reduction in the tumor growth was observed